Please Wait.....
Report
Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Immunology, Stem Cell, Apoptosis), Clinical (Cancer)) - Global Forecast to 2032
Market Report I 2024-06-11 I 531 Pages I MarketsandMarkets
The global flow cytometry market is estimated to reach USD 10.3 Billion by 2032 from USD 5.1 billion in 2024, at a CAGR of 9.2% during the forecast period of 2024 to 2032. Advancements in reagent technologies, such as fluorophore conjugation and specificity enhancement is one of the major factor uplifting the market growth. The dominance of the reagents and consumables segment among product and services factors is notable in the flow cytometry market. This segment holds sway due to continuous demand for antibodies, dyes, and other consumables essential for cell analysis. As the use of flow cytometry expands in research, clinical diagnostics, and drug development, the need for high-quality reagents remains constant.
"Cell-Based flow cytometry market is likely to grow at faster pace"
Based on the technology, the flow cytometry market is cell-based and bead-based flow cytomtery. Cell-based flow cytometry segment dominated the market in 2023. The dominance of cell-based flow cytometry in the technology segment is pronounced due to its versatility in analyzing various cell types and biomarkers. Its ability to provide quantitative and qualitative data swiftly has made it indispensable in biomedical research, clinical diagnostics, and drug discovery, thus driving its market significance.
"The research application dominated the applications segments"
Based on the end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. The research application dominanted the segment however clinical application is anticipated to grow at significant CAGR during the forecast period. The extensive use of flow cytometry in basic and translational research across diverse fields such as immunology, oncology, and microbiology is likely to drive the segmental growth.
"Asia Pacific region estimated to show fastest growth rate."
Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the flow cytometry market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as as increasing investment in healthcare infrastructure, rising R&D activities in life sciences, and growing awareness about personalized medicine are driving this growth. Moreover, countries like China, Japan, India, and South Korea are witnessing substantial adoption of flow cytometry technologies in research, clinical diagnostics, and drug discovery.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70%, and Demand Side - 30%
- By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%
List of Companies Profiled in the Report:
- Becton, Dickinson and Company (US)
- Danaher Corporation (US)
- Thermo Fisher Scientific Inc. (US)
- Agilent Technologies, Inc. (US)
- Sony Corporation (Japan)
- Bio-Rad Laboratories, Inc. (US)
- Miltenyi Biotec (Germany)
- Enzo Biochem, Inc. (US)
- Sysmex Corporation (Japan)
- bioMerieux (France)
- Cytonome/ST, LLC (US)
- Sartorius AG (Germany)
- Cytek Biosciences (US)
- Union Biometrica, Inc. (US)
- Takara Bio Inc. (Japan)
- Apogee Flow Systems Ltd. (UK)
- Stratedigm, Inc. (US)
- NanoCellect Biomedical, Inc. (US)
- On-chip Biotechnologies, Co., Ltd. (Japan)
- Nexcelom Biosciences LLC. (US)
- BennuBio Inc. (US)
- Orflo Technologies (US)
- Bay Biosciences Co., Ltd. (Japan)
- BioLegend, Inc. (US)
- CytoBuoy B.V (Netherlands)
Research Coverage:
This report provides a detailed picture of the flow cytometry market. It aims at estimating the size and future growth potential of the market across different segments such as technology, product & services, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the estimations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key Drivers (Increasing prevalence of chronic diseases, growing use of flow cytometry in regenerative medicines, Increasing collaborations, strategic partnerships, and alliances among key players, launch of technologically advanced flow cytometry products), restraints (High cost of instruments ), opportunities (Increased use in clinical applications and infectious disease diagnostics), and challenges (Complexities related to reagent development) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the flow cytometry market.
- Market Development: Comprehensive information about lucrative markets the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the flow cytometry market.
- Competitive Assessment: In-depth assessment of market shares of key players, growth strategies, and products offerings of leading players like Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMerieux (France), Cytonome/ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences (US), Union Biometrica, Inc. (US), Takara Bio Inc. (Japan), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), Nexcelom Biosciences LLC. (US), BennuBio Inc. (US), Orflo Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands)
1 INTRODUCTION 73
1.1 STUDY OBJECTIVES 73
1.2 MARKET DEFINITION 73
1.2.1 INCLUSIONS AND EXCLUSIONS 74
TABLE 1 FLOW CYTOMETRY MARKET: INCLUSIONS AND EXCLUSIONS 74
1.3 STUDY SCOPE 74
1.3.1 SEGMENTS COVERED 74
FIGURE 1 FLOW CYTOMETRY MARKET: SEGMENTS COVERED 74
1.3.2 REGIONS COVERED 75
FIGURE 2 FLOW CYTOMETRY MARKET: REGIONS COVERED 75
1.3.3 YEARS CONSIDERED 75
FIGURE 3 FLOW CYTOMETRY MARKET: YEARS CONSIDERED 75
1.3.4 CURRENCY CONSIDERED 76
1.4 STAKEHOLDERS 76
1.5 SUMMARY OF CHANGES 76
1.5.1 RECESSION IMPACT 77
2 RESEARCH METHODOLOGY 78
2.1 RESEARCH DATA 78
FIGURE 4 FLOW CYTOMETRY MARKET: RESEARCH DESIGN 78
2.1.1 SECONDARY DATA 79
2.1.1.1 Objectives of secondary research 79
2.1.2 PRIMARY DATA 80
2.1.2.1 Breakdown of primaries 80
FIGURE 5 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES 80
2.1.2.2 Objectives of primary research 81
2.2 MARKET SIZE ESTIMATION 81
FIGURE 6 FLOW CYTOMETRY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 81
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH), 2023 82
FIGURE 8 ILLUSTRATIVE EXAMPLE OF BECTON, DICKINSON AND COMPANY: REVENUE SHARE ANALYSIS (2023) 82
2.2.1 INSIGHTS FROM PRIMARIES 84
FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS 84
2.2.2 SEGMENT ASSESSMENT (BY TECHNOLOGY, PRODUCT & SERVICE, APPLICATION, AND END USER) 84
FIGURE 10 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 84
2.3 GROWTH RATE ASSUMPTIONS 85
FIGURE 11 FLOW CYTOMETRY MARKET: CAGR PROJECTIONS, 2024-2032 86
FIGURE 12 FLOW CYTOMETRY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 86
2.3.1 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 87
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS IN FLOW CYTOMETRY MARKET 87
2.4 STUDY ASSUMPTIONS 87
2.5 DATA TRIANGULATION 88
FIGURE 13 DATA TRIANGULATION METHODOLOGY 88
2.6 RISK ANALYSIS 89
TABLE 3 FLOW CYTOMETRY MARKET: RISK ANALYSIS 89
2.7 RESEARCH LIMITATIONS 89
2.8 IMPACT OF ECONOMIC RECESSION ON FLOW CYTOMETRY MARKET 89
3 EXECUTIVE SUMMARY 91
FIGURE 14 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2024 VS. 2032 (USD MILLION) 91
FIGURE 15 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2024 VS. 2032 (USD MILLION) 92
FIGURE 16 FLOW CYTOMETRY MARKET, BY APPLICATION, 2024 VS. 2032 (USD MILLION) 92
FIGURE 17 FLOW CYTOMETRY MARKET, BY END USER, 2024 VS. 2032 (USD MILLION) 93
FIGURE 18 FLOW CYTOMETRY MARKET: REGIONAL SNAPSHOT (2024-2032) 94
4 PREMIUM INSIGHTS 95
4.1 FLOW CYTOMETRY MARKET OVERVIEW 95
FIGURE 19 RISING PREVALENCE OF CANCER AND AUTOIMMUNE DISEASES TO DRIVE MARKET 95
4.2 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE AND COUNTRY (2023) 96
FIGURE 20 US AND REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 96
4.3 FLOW CYTOMETRY MARKET, BY TECHNOLOGY (2024 VS. 2032) 97
FIGURE 21 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 97
4.4 FLOW CYTOMETRY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES (2024-2032) 97
FIGURE 22 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 97
5 MARKET OVERVIEW 98
5.1 INTRODUCTION 98
5.2 MARKET DYNAMICS 98
FIGURE 23 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 98
5.2.1 DRIVERS 99
5.2.1.1 Increasing prevalence and demand for testing for chronic disease 99
TABLE 4 INCIDENCE OF HIV/AIDS GLOBALLY, BY REGION, 2022 99
TABLE 5 GLOBAL INCIDENCE OF CANCER, BY REGION, 2020 VS. 2040 99
5.2.1.2 Growing use of flow cytometry in regenerative medicines 100
TABLE 6 ESTIMATED EXPENDITURE BY NATIONAL INSTITUTES OF HEALTH FOR STEM CELL RESEARCH, 2019-2024 101
5.2.1.3 Increasing collaborations, strategic partnerships, and alliances among key players 101
5.2.1.4 Launch of technologically advanced flow cytometry products 102
TABLE 7 KEY PRODUCT LAUNCHES IN FLOW CYTOMETRY MARKET, JANUARY 2021-MAY 2024 102
5.2.2 RESTRAINTS 103
5.2.2.1 High cost of instruments 103
5.2.3 OPPORTUNITIES 104
5.2.3.1 Increased use in clinical applications and infectious disease diagnostics 104
5.2.4 CHALLENGES 104
5.2.4.1 Complexities related to reagent development 104
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 105
FIGURE 24 RISING USE OF FLOW CYTOMETRY IN CLINICAL APPLICATIONS 105
5.4 VALUE CHAIN ANALYSIS 105
FIGURE 25 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS 106
5.5 ECOSYSTEM ANALYSIS 107
FIGURE 26 FLOW CYTOMETRY MARKET: ECOSYSTEM MAP 107
5.5.1 INSTRUMENT & SOFTWARE PROVIDERS 107
TABLE 8 LIST OF KEY INSTRUMENT PROVIDERS IN FLOW CYTOMETRY MARKET 108
5.5.2 REAGENT & CONSUMABLE PROVIDERS 108
TABLE 9 LIST OF KEY REAGENT & CONSUMABLE PROVIDERS IN FLOW CYTOMETRY MARKET 108
5.5.3 END USERS 109
TABLE 10 LIST OF KEY END USERS IN FLOW CYTOMETRY MARKET 109
5.5.4 REGULATORY BODIES 109
TABLE 11 LIST OF KEY REGULATORY BODIES IN FLOW CYTOMETRY MARKET 110
5.6 REGULATORY ANALYSIS 110
5.6.1 REGULATORY LANDSCAPE 110
5.6.1.1 Stringent FDA requirements 110
5.6.1.2 Analyte-specific reagent rules 110
5.6.1.3 Limitations in validation protocols for cell-based assays 111
5.6.1.4 Absence of test guidelines for cell-based fluorescence assays 111
5.6.1.5 IVD CE mark approvals 111
5.6.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
5.6.2.1 North America: List of regulatory bodies, government agencies, and other organizations 111
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
5.6.2.2 Europe: List of regulatory bodies, government agencies, and other organizations 112
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112
5.6.2.3 Asia Pacific: List of regulatory bodies, government agencies, and other organizations 113
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
5.6.2.4 Latin America: List of regulatory bodies, government agencies, and other organizations 114
TABLE 15 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
5.6.2.5 Middle East & Africa: List of regulatory bodies, government agencies, and other organizations 114
TABLE 16 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
5.7 PORTER'S FIVE FORCES ANALYSIS 115
TABLE 17 FLOW CYTOMETRY MARKET: PORTER'S FIVE FORCES ANALYSIS 115
FIGURE 27 FLOW CYTOMETRY MARKET: PORTER'S FIVE FORCES ANALYSIS 115
5.7.1 INTENSITY OF COMPETITIVE RIVALRY 116
5.7.2 BARGAINING POWER OF SUPPLIERS 116
5.7.3 BARGAINING POWER OF BUYERS 116
5.7.4 THREAT OF SUBSTITUTES 116
5.7.5 THREAT OF NEW ENTRANTS 117
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 117
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 118
FIGURE 28 FLOW CYTOMETRY MARKET: KEY STAKEHOLDERS IN BUYING PROCESS 118
TABLE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 118
5.8.2 KEY BUYING CRITERIA 119
FIGURE 29 FLOW CYTOMETRY MARKET: KEY BUYING CRITERIA 119
5.9 TECHNOLOGY ANALYSIS 120
5.9.1 KEY TECHNOLOGIES 120
5.9.1.1 Spectral flow cytometry 120
5.9.1.2 Mass cytometry 120
5.9.1.3 Imaging flow cytometry 120
5.9.2 ADJACENT TECHNOLOGIES 121
5.9.2.1 Single-cell RNA sequencing 121
5.9.2.2 Microfluidics 121
5.9.2.3 High-content screening 121
5.9.3 COMPLEMENTARY TECHNOLOGIES 121
5.9.3.1 Single-cell analysis 122
5.9.3.2 Spatial analysis 122
5.10 PATENT ANALYSIS 122
5.10.1 METHODOLOGY 122
5.10.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014-2024 122
TABLE 19 NUMBER OF PATENTS FILED IN FLOW CYTOMETRY MARKET, 2014-2024 122
5.10.3 INNOVATION AND PATENT APPLICATIONS 123
FIGURE 30 TOTAL NUMBER OF PATENTS GRANTED ANNUALLY, 2014-2023 123
5.10.4 TOP APPLICANTS FOR PATENTS, 2014-2024 123
FIGURE 31 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2024 123
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014-2024 124
TABLE 20 TOP 12 PATENT OWNERS IN US FLOW CYTOMETRY MARKET, 2014-2024 124
TABLE 21 DETAILED ANALYSIS OF KEY PATENTS IN FLOW CYTOMETRY MARKET, 2022-2024 125
5.11 INVESTMENT AND FUNDING SCENARIO 127
5.12 INDICATIVE PRICING ANALYSIS 128
5.12.1 INDICATIVE PRICING ANALYSIS OF CELL ANALYZERS AND CELL SORTERS, BY RANGE, 2023 128
TABLE 22 COST OF CELL ANALYZERS AND CELL SORTERS, BY RANGE, 2023 128
5.12.2 INDICATIVE PRICING ANALYSIS OF FLOW CYTOMETRY INSTRUMENTS, BY KEY PLAYER, 2023 128
TABLE 23 COST OF FLOW CYTOMETRY INSTRUMENTS, BY KEY PLAYER, 2023 128
5.12.3 INDICATIVE PRICING ANALYSIS OF FLOW CYTOMETRY REAGENTS & CONSUMABLES, BY KEY PLAYER, 2023 129
TABLE 24 COST OF FLOW CYTOMETRY REAGENTS & CONSUMABLES, BY KEY PLAYER, 2023 129
5.12.4 COST OF FLOW CYTOMETRY SOFTWARE, 2023 130
5.13 KEY CONFERENCES AND EVENTS, 2024-2025 130
TABLE 25 FLOW CYTOMETRY MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024-DECEMBER 2025 130
5.14 TRADE DATA ANALYSIS 131
5.14.1 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2017-2021 131
TABLE 26 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017-2021 (USD THOUSAND) 131
5.14.2 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2017-2021 132
TABLE 27 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017-2021 (USD THOUSAND) 132
5.14.3 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022-2023 133
TABLE 28 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022-2023 (USD THOUSAND) 133
TABLE 29 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022-2023 (UNITS) 134
5.14.4 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022-2023 135
TABLE 30 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022-2023 (USD THOUSAND) 135
TABLE 31 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022-2023 (UNITS) 136
?
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 137
6.1 INTRODUCTION 138
TABLE 32 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD BILLION) 138
6.2 CELL-BASED FLOW CYTOMETRY 138
6.2.1 INCREASED FOCUS ON R&D AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET GROWTH 138
TABLE 33 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2022-2032 (USD BILLION) 139
TABLE 34 NORTH AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD BILLION) 139
TABLE 35 EUROPE: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD BILLION) 140
TABLE 36 ASIA PACIFIC: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD BILLION) 140
TABLE 37 LATIN AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 141
TABLE 38 MIDDLE EAST: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 141
TABLE 39 GCC COUNTRIES: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION)) 142
6.3 BEAD-BASED FLOW CYTOMETRY 142
6.3.1 HIGHER RELIABILITY AND BETTER MEASUREMENT CONSISTENCIES TO SUPPORT MARKET GROWTH 142
TABLE 40 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2022-2032 (USD BILLION) 143
TABLE 41 NORTH AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 144
TABLE 42 EUROPE: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 144
TABLE 43 ASIA PACIFIC: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 145
TABLE 44 LATIN AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 145
TABLE 45 MIDDLE EAST: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 146
TABLE 46 GCC COUNTRIES: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 146
7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 147
7.1 INTRODUCTION 148
TABLE 47 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD BILLION) 148
7.2 REAGENTS & CONSUMABLES 148
TABLE 48 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD BILLION) 149
TABLE 49 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022-2032 (USD BILLION) 149
TABLE 50 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2032 (USD BILLION) 150
TABLE 51 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2032 (USD BILLION) 150
TABLE 52 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2032 (USD BILLION) 151
TABLE 53 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2032 (USD MILLION) 151
TABLE 54 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2032 (USD MILLION) 152
TABLE 55 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2032 (USD MILLION) 152
7.2.1 ANTIBODIES 152
7.2.1.1 Increasing demand for high-specificity antibodies to propel market growth 152
TABLE 56 ANTIBODIES MARKET, BY REGION, 2022-2032 (USD BILLION) 153
TABLE 57 NORTH AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 153
TABLE 58 EUROPE: ANTIBODIES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 154
TABLE 59 ASIA PACIFIC: ANTIBODIES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 154
TABLE 60 LATIN AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 155
TABLE 61 MIDDLE EAST: ANTIBODIES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 155
TABLE 62 GCC COUNTRIES: ANTIBODIES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 155
7.2.2 ASSAYS & KITS 156
7.2.2.1 Need for high-precision diagnosis and advancements in personalized medicines to aid market growth 156
TABLE 63 ASSAYS & KITS MARKET, BY REGION, 2022-2032 (USD BILLION) 157
TABLE 64 NORTH AMERICA: ASSAYS & KITS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 157
TABLE 65 EUROPE: ASSAYS & KITS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 158
TABLE 66 ASIA PACIFIC: ASSAYS & KITS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 158
TABLE 67 LATIN AMERICA: ASSAYS & KITS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 159
TABLE 68 MIDDLE EAST: ASSAYS & KITS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 159
TABLE 69 GCC COUNTRIES: ASSAYS & KITS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 159
7.2.3 OTHER REAGENTS & CONSUMABLES 160
TABLE 70 OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2022-2032 (USD BILLION) 160
TABLE 71 NORTH AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 161
TABLE 72 EUROPE: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 161
TABLE 73 ASIA PACIFIC: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 162
TABLE 74 LATIN AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 162
TABLE 75 MIDDLE EAST: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 163
TABLE 76 GCC COUNTRIES: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 163
7.3 INSTRUMENTS 163
TABLE 77 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD BILLION) 164
TABLE 78 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (UNITS) 164
TABLE 79 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 (USD BILLION) 165
TABLE 80 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 (USD BILLION) 165
TABLE 81 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 (USD MILLION) 166
TABLE 82 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 (USD MILLION) 166
TABLE 83 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 (USD MILLION) 167
TABLE 84 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 (USD MILLION) 167
TABLE 85 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 (USD MILLION) 168
7.3.1 CELL ANALYZERS 168
TABLE 86 CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 169
TABLE 87 CELL ANALYZERS MARKET, BY REGION, 2022-2032 (USD BILLION) 169
TABLE 88 NORTH AMERICA: CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD BILLION) 170
TABLE 89 EUROPE: CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 170
TABLE 90 ASIA PACIFIC: CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 171
TABLE 91 LATIN AMERICA: CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 171
TABLE 92 MIDDLE EAST: CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 172
TABLE 93 GCC COUNTRIES: CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 172
7.3.1.1 High-range cell analyzers 172
7.3.1.1.1 Better sensitivity, accuracy, and flexibility in designing multicolor experiments to augment segment growth 172
TABLE 94 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2022-2032 (USD BILLION) 173
TABLE 95 NORTH AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 173
TABLE 96 EUROPE: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 174
TABLE 97 ASIA PACIFIC: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 174
TABLE 98 LATIN AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 175
TABLE 99 MIDDLE EAST: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 175
TABLE 100 GCC COUNTRIES: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 176
7.3.1.2 Mid-range cell analyzers 176
7.3.1.2.1 Availability of compact and high-performance analyzers to support market growth 176
TABLE 101 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2022-2032 (USD BILLION) 176
TABLE 102 NORTH AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 177
TABLE 103 EUROPE: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 177
TABLE 104 ASIA PACIFIC: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 178
TABLE 105 LATIN AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 178
TABLE 106 MIDDLE EAST: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 179
TABLE 107 GCC COUNTRIES: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 179
7.3.1.3 Low-range cell analyzers 179
7.3.1.3.1 Cost-effectiveness and increased commercialization by manufacturers to drive segment 179
TABLE 108 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2022-2032 (USD MILLION) 180
TABLE 109 NORTH AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 180
TABLE 110 EUROPE: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 181
TABLE 111 ASIA PACIFIC: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 181
TABLE 112 LATIN AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 182
TABLE 113 MIDDLE EAST: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 182
TABLE 114 GCC COUNTRIES: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 183
7.3.2 CELL SORTERS 183
TABLE 115 LIST OF KEY CELL SORTERS AVAILABLE IN MARKET 184
TABLE 116 CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 184
TABLE 117 CELL SORTERS MARKET, BY REGION, 2022-2032 (USD MILLION 185
TABLE 118 NORTH AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 185
TABLE 119 EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 186
TABLE 120 ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 186
TABLE 121 LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 187
TABLE 122 MIDDLE EAST: CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 187
TABLE 123 GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 187
7.3.2.1 High-range cell sorters 188
7.3.2.1.1 High cost and budget constraints among end users to limit market growth 188
TABLE 124 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2022-2032 (USD MILLION) 188
TABLE 125 NORTH AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 188
TABLE 126 EUROPE: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 189
TABLE 127 ASIA PACIFIC: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 189
TABLE 128 LATIN AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 190
TABLE 129 MIDDLE EAST: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 190
TABLE 130 GCC COUNTRIES: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 191
7.3.2.2 Mid-range cell sorters 191
7.3.2.2.1 Cost-effectiveness and high availability to spur market growth 191
TABLE 131 MID-RANGE CELL SORTERS MARKET, BY REGION, 2022-2032 (USD MILLION) 191
TABLE 132 NORTH AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 192
TABLE 133 EUROPE: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 192
TABLE 134 ASIA PACIFIC: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 193
TABLE 135 LATIN AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 193
TABLE 136 MIDDLE EAST: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 194
7.3.2.3 Low-range cell sorters 194
7.3.2.3.1 Increasing commercialization in small-scale laboratories and research facilities to fuel market growth 194
TABLE 137 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2022-2032 (USD MILLION) 194
TABLE 138 NORTH AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 195
TABLE 139 EUROPE: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 195
TABLE 140 ASIA PACIFIC: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 196
TABLE 141 LATIN AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 196
7.4 SERVICES 197
7.4.1 RISING FOCUS ON WORKFLOW CONTINUITY AND PERFORMANCE MAXIMIZATION TO BOOST MARKET GROWTH 197
TABLE 142 FLOW CYTOMETRY MARKET FOR SERVICES, BY REGION, 2022-2032 (USD MILLION) 197
TABLE 143 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022-2032 (USD MILLION) 198
TABLE 144 EUROPE: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022-2032 (USD MILLION) 198
TABLE 145 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022-2032 (USD MILLION) 199
TABLE 146 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022-2032 (USD MILLION) 199
TABLE 147 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022-2032 (USD MILLION) 200
TABLE 148 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022-2032 (USD MILLION) 200
7.5 SOFTWARE 200
7.5.1 INCREASING AVAILABILITY OF DATA ANALYSIS SOFTWARE TO AID MARKET GROWTH 200
TABLE 149 FLOW CYTOMETRY MARKET FOR SOFTWARE, BY REGION, 2022-2032 (USD MILLION) 201
TABLE 150 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022-2032 (USD MILLION) 202
TABLE 151 EUROPE: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022-2032 (USD MILLION) 202
TABLE 152 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022-2032 (USD MILLION) 203
TABLE 153 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022-2032 (USD MILLION) 203
TABLE 154 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022-2032 (USD MILLION) 204
7.6 ACCESSORIES 204
7.6.1 HIGH AVAILABILITY OF ADVANCED AND CUSTOMIZED ACCESSORIES TO SUPPORT MARKET GROWTH 204
TABLE 155 FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY REGION, 2022-2032 (USD MILLION) 205
TABLE 156 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022-2032 (USD MILLION) 205
TABLE 157 EUROPE: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022-2032 (USD MILLION) 206
TABLE 158 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022-2032 (USD MILLION) 206
TABLE 159 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022-2032 (USD MILLION) 207
TABLE 160 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022-2032 (USD MILLION) 207
8 FLOW CYTOMETRY MARKET, BY APPLICATION 208
8.1 INTRODUCTION 209
TABLE 161 FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD BILLION) 209
8.2 RESEARCH APPLICATIONS 209
TABLE 162 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 210
TABLE 163 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2032 (USD BILLION) 210
TABLE 164 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2032 (USD BILLION) 211
TABLE 165 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2032 (USD BILLION) 211
TABLE 166 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 212
TABLE 167 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 212
TABLE 168 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 213
TABLE 169 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 213
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY 213
TABLE 170 PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD BILLION) 214
TABLE 171 PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY REGION, 2022-2032 (USD BILLION) 214
TABLE 172 NORTH AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD BILLION) 215
TABLE 173 EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 215
TABLE 174 ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 216
TABLE 175 LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 216
TABLE 176 MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 217
TABLE 177 GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 217
8.2.1.1 Drug discovery 217
8.2.1.1.1 Growing use of phenotypic cell-based assays to support market growth 217
TABLE 178 DRUG DISCOVERY MARKET, BY REGION, 2022-2032 (USD BILLION) 218
TABLE 179 NORTH AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 219
TABLE 180 EUROPE: DRUG DISCOVERY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 219
TABLE 181 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 220
TABLE 182 LATIN AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 220
TABLE 183 MIDDLE EAST: DRUG DISCOVERY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 221
TABLE 184 GCC COUNTRIES: DRUG DISCOVERY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 221
8.2.1.2 Stem cell research 221
8.2.1.2.1 Increasing R&D and rising investments for advanced stem cell development to drive segment 221
TABLE 185 STEM CELL RESEARCH MARKET, BY REGION, 2022-2032 (USD MILLION) 222
TABLE 186 NORTH AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 223
TABLE 187 EUROPE: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 223
TABLE 188 ASIA PACIFIC: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 224
TABLE 189 LATIN AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 224
TABLE 190 MIDDLE EAST: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 225
TABLE 191 GCC COUNTRIES: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 225
8.2.1.3 In vitro toxicity testing 225
8.2.1.3.1 Focus on continuous drug development by pharmaceutical & biotechnology companies to aid segment growth 225
TABLE 192 IN VITRO TOXICITY TESTING MARKET, BY REGION, 2022-2032 (USD MILLION) 226
TABLE 193 NORTH AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 226
TABLE 194 EUROPE: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 227
TABLE 195 ASIA PACIFIC: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 227
TABLE 196 LATIN AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 228
TABLE 197 MIDDLE EAST: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 228
8.2.2 IMMUNOLOGY 228
8.2.2.1 Growing prevalence of chronic autoimmune diseases to drive market 228
TABLE 198 IMMUNOLOGY MARKET, BY REGION, 2022-2032 (USD BILLION) 229
TABLE 199 NORTH AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 229
TABLE 200 EUROPE: IMMUNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 230
TABLE 201 ASIA PACIFIC: IMMUNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 230
TABLE 202 LATIN AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 231
TABLE 203 MIDDLE EAST: IMMUNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 231
TABLE 204 GCC COUNTRIES: IMMUNOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 231
8.2.3 CELL SORTING 232
8.2.3.1 Increasing focus on cell-based research activities to fuel market growth 232
TABLE 205 CELL SORTING MARKET, BY REGION, 2022-2032 (USD BILLION) 233
TABLE 206 NORTH AMERICA: CELL SORTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 233
TABLE 207 EUROPE: CELL SORTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 234
TABLE 208 ASIA PACIFIC: CELL SORTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 234
TABLE 209 LATIN AMERICA: CELL SORTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 235
TABLE 210 MIDDLE EAST: CELL SORTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 235
TABLE 211 GCC COUNTRIES: CELL SORTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 235
8.2.4 APOPTOSIS 236
8.2.4.1 Increased use in research activities to drive segment 236
TABLE 212 APOPTOSIS MARKET, BY REGION, 2022-2032 (USD MILLION) 236
TABLE 213 NORTH AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 237
TABLE 214 EUROPE: APOPTOSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 237
TABLE 215 ASIA PACIFIC: APOPTOSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 238
TABLE 216 LATIN AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 238
TABLE 217 MIDDLE EAST: APOPTOSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 239
TABLE 218 GCC COUNTRIES: APOPTOSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 239
8.2.5 CELL CYCLE ANALYSIS 239
8.2.5.1 High accuracy of cytometry products in cell analysis to propel segment growth 239
TABLE 219 CELL CYCLE ANALYSIS MARKET, BY REGION, 2022-2032 (USD MILLION) 240
TABLE 220 NORTH AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 240
TABLE 221 EUROPE: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 241
TABLE 222 ASIA PACIFIC: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 241
TABLE 223 LATIN AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 242
TABLE 224 MIDDLE EAST: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 242
TABLE 225 GCC COUNTRIES: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 242
8.2.6 CELL VIABILITY 243
8.2.6.1 Growing use of cell viability assays in research to support market growth 243
TABLE 226 CELL VIABILITY MARKET, BY REGION, 2022-2032 (USD MILLION) 243
TABLE 227 NORTH AMERICA: CELL VIABILITY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 244
TABLE 228 EUROPE: CELL VIABILITY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 244
TABLE 229 ASIA PACIFIC: CELL VIABILITY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 245
TABLE 230 LATIN AMERICA: CELL VIABILITY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 245
TABLE 231 MIDDLE EAST: CELL VIABILITY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 246
TABLE 232 GCC COUNTRIES: CELL VIABILITY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 246
8.2.7 CELL COUNTING 246
8.2.7.1 Rising need for multi-parametric cellular assessments to spur market growth 246
TABLE 233 CELL COUNTING MARKET, BY REGION, 2022-2032 (USD MILLION) 247
TABLE 234 NORTH AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 247
TABLE 235 EUROPE: CELL COUNTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 248
TABLE 236 ASIA PACIFIC: CELL COUNTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 248
TABLE 237 LATIN AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 249
TABLE 238 MIDDLE EAST: CELL COUNTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 249
TABLE 239 GCC COUNTRIES: CELL COUNTING MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 249
8.2.8 OTHER RESEARCH APPLICATIONS 250
TABLE 240 OTHER RESEARCH APPLICATIONS MARKET, BY REGION, 2022-2032 (USD MILLION) 250
TABLE 241 NORTH AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 250
TABLE 242 EUROPE: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 251
TABLE 243 ASIA PACIFIC: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 251
TABLE 244 LATIN AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 252
TABLE 245 MIDDLE EAST: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 252
8.3 CLINICAL APPLICATIONS 252
TABLE 246 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 253
TABLE 247 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2032 (USD BILLION) 254
TABLE 248 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 254
TABLE 249 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD BILLION) 255
TABLE 250 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD BILLION) 255
TABLE 251 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 256
TABLE 252 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 256
TABLE 253 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 257
8.3.1 CANCER DIAGNOSTICS 257
8.3.1.1 Increasing prevalence of cancer to drive segment 257
TABLE 254 ESTIMATED NUMBER OF NEW CANCER CASES (2020-2040) 257
TABLE 255 CANCER DIAGNOSTICS MARKET, BY REGION, 2022-2032 (USD MILLION) 258
TABLE 256 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 259
TABLE 257 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 259
TABLE 258 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 260
TABLE 259 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 260
TABLE 260 MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 261
TABLE 261 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2022-2032 (USD MILLION) 261
8.3.2 HEMATOLOGY 261
8.3.2.1 Multi-parametric approach and high-speed cell analyzing capabilities to augment segment growth 261
TABLE 262 HEMATOLOGY MARKET, BY REGION, 2022-2032 (USD MILLION) 262
TABLE 263 NORTH AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 262
TABLE 264 EUROPE: HEMATOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 263
TABLE 265 ASIA PACIFIC: HEMATOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 263
TABLE 266 LATIN AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 264
TABLE 267 MIDDLE EAST: HEMATOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 264
TABLE 268 GCC COUNTRIES: HEMATOLOGY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 264
8.3.3 AUTOIMMUNE DISEASES 265
8.3.3.1 Growing focus on developing treatments for autoimmune diseases to drive segment 265
TABLE 269 AUTOIMMUNE DISEASES MARKET, BY REGION, 2022-2032 (USD MILLION) 266
TABLE 270 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 266
TABLE 271 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 267
TABLE 272 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 267
TABLE 273 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 268
TABLE 274 MIDDLE EAST: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 268
TABLE 275 GCC COUNTRIES: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 269
8.3.4 ORGAN TRANSPLANTATION 269
8.3.4.1 Rising number of organ transplants to propel market growth 269
FIGURE 33 NUMBER OF ORGAN TRANSPLANTS IN US (2024) 270
TABLE 276 ORGAN TRANSPLANTATION MARKET, BY REGION, 2022-2032 (USD MILLION) 271
TABLE 277 NORTH AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 271
TABLE 278 EUROPE: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 272
TABLE 279 ASIA PACIFIC: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 272
TABLE 280 LATIN AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 273
TABLE 281 MIDDLE EAST: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 273
TABLE 282 GCC COUNTRIES: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 274
8.3.5 OTHER CLINICAL APPLICATIONS 274
TABLE 283 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022-2032 (USD MILLION) 275
TABLE 284 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 275
TABLE 285 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 276
TABLE 286 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 276
8.4 INDUSTRIAL APPLICATIONS 277
8.4.1 INCREASING USE IN FOOD, DAIRY, ENERGY, AND MICROBIAL INDUSTRIES TO SUPPORT MARKET GROWTH 277
TABLE 287 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022-2032 (USD MILLION) 277
TABLE 288 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 278
TABLE 289 EUROPE: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 278
TABLE 290 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 279
TABLE 291 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 279
TABLE 292 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 280
TABLE 293 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022-2032 (USD MILLION) 280
9 FLOW CYTOMETRY MARKET, BY END USER 281
9.1 INTRODUCTION 282
TABLE 294 FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD BILLION) 282
9.2 ACADEMIC & RESEARCH INSTITUTES 282
9.2.1 RISING PUBLIC-PRIVATE FUNDING AND INCREASING CANCER RESEARCH PROJECTS TO DRIVE MARKET 282
TABLE 295 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2032 (USD BILLION) 284
TABLE 296 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 (USD BILLION) 284
TABLE 297 EUROPE: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 (USD BILLION) 285
TABLE 298 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 (USD BILLION) 285
TABLE 299 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 (USD MILLION) 286
TABLE 300 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 (USD MILLION) 286
TABLE 301 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 (USD MILLION) 287
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 287
9.3.1 GROWING DEMAND FOR EFFECTIVE DISEASE DIAGNOSIS AND TREATMENT TO SPUR MARKET GROWTH 287
TABLE 302 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2022-2032 (USD BILLION) 288
TABLE 303 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022-2032 (USD BILLION) 288
TABLE 304 EUROPE: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022-2032 (USD BILLION) 289
TABLE 305 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022-2032 (USD MILLION) 289
TABLE 306 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022-2032 (USD MILLION) 290
TABLE 307 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022-2032 (USD MILLION) 290
TABLE 308 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022-2032 (USD MILLION) 291
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 291
9.4.1 INCREASING FOCUS ON PERSONALIZED MEDICINE AND TARGETED THERAPIES TO FUEL MARKET GROWTH 291
TABLE 309 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 (USD BILLION) 292
TABLE 310 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 (USD MILLION) 292
TABLE 311 EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 (USD MILLION) 293
TABLE 312 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 (USD MILLION) 293
TABLE 313 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 (USD MILLION) 294
TABLE 314 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 (USD MILLION) 294
TABLE 315 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 (USD MILLION) 295
10 FLOW CYTOMETRY MARKET, BY REGION 296
10.1 INTRODUCTION 297
TABLE 316 FLOW CYTOMETRY MARKET, BY REGION, 2022-2032 (USD BILLION) 297
10.2 NORTH AMERICA 298
FIGURE 34 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 298
TABLE 317 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD BILLION) 299
TABLE 318 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD BILLION) 299
TABLE 319 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD BILLION) 299
TABLE 320 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD BILLION) 300
TABLE 321 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD BILLION) 300
TABLE 322 NORTH AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 300
TABLE 323 NORTH AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 301
TABLE 324 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD BILLION) 301
TABLE 325 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 302
TABLE 326 NORTH AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD BILLION) 302
TABLE 327 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 303
TABLE 328 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD BILLION) 303
10.2.1 NORTH AMERICA: RECESSION IMPACT 303
10.2.2 US 304
10.2.2.1 US to dominate North American flow cytometry market during study period 304
TABLE 329 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD BILLION) 305
TABLE 330 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD BILLION) 305
TABLE 331 US: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD BILLION) 305
TABLE 332 US: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD BILLION) 306
TABLE 333 US: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 306
TABLE 334 US: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 306
TABLE 335 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD BILLION) 307
TABLE 336 US: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 307
TABLE 337 US: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD BILLION) 308
TABLE 338 US: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 308
TABLE 339 US: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD BILLION) 309
10.2.3 CANADA 309
10.2.3.1 Ongoing government initiatives for life science research and high incidence of cancer to propel market growth 309
TABLE 340 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 310
TABLE 341 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 311
TABLE 342 CANADA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 311
TABLE 343 CANADA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 312
TABLE 344 CANADA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 312
TABLE 345 CANADA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 312
TABLE 346 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 313
TABLE 347 CANADA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 313
TABLE 348 CANADA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 314
TABLE 349 CANADA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 314
TABLE 350 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 315
10.3 EUROPE 315
TABLE 351 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD BILLION) 316
TABLE 352 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD BILLION) 316
TABLE 353 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD BILLION) 317
TABLE 354 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD BILLION) 317
TABLE 355 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD BILLION) 318
TABLE 356 EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 318
TABLE 357 EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 318
TABLE 358 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD BILLION) 319
TABLE 359 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 319
TABLE 360 EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD BILLION) 320
TABLE 361 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 320
TABLE 362 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD BILLION) 321
10.3.1 EUROPE: RECESSION IMPACT 321
10.3.2 GERMANY 322
10.3.2.1 Increasing public and private funding for advanced cell-based research activities to aid market growth 322
TABLE 363 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 322
TABLE 364 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 323
TABLE 365 GERMANY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 323
TABLE 366 GERMANY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 324
TABLE 367 GERMANY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 324
TABLE 368 GERMANY: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 324
TABLE 369 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 325
TABLE 370 GERMANY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 325
TABLE 371 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 326
TABLE 372 GERMANY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 326
TABLE 373 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 327
10.3.3 UK 327
10.3.3.1 Growing acceptance of flow cytometry-based diagnostic techniques by healthcare professionals to spur market growth 327
TABLE 374 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 328
TABLE 375 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 328
TABLE 376 UK: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 329
TABLE 377 UK: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 329
TABLE 378 UK: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 329
TABLE 379 UK: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 330
TABLE 380 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 330
TABLE 381 UK: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 331
TABLE 382 UK: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 331
TABLE 383 UK: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 332
TABLE 384 UK: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 332
10.3.4 FRANCE 332
10.3.4.1 Increasing government funding for proteomics and genomics research to fuel market growth 332
TABLE 385 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 333
TABLE 386 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 333
TABLE 387 FRANCE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 334
TABLE 388 FRANCE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 334
TABLE 389 FRANCE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 334
TABLE 390 FRANCE: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 335
TABLE 391 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 335
TABLE 392 FRANCE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 336
TABLE 393 FRANCE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 336
TABLE 394 FRANCE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 337
TABLE 395 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 337
10.3.5 ITALY 337
10.3.5.1 Large geriatric population and presence of well-developed healthcare system to boost market growth 337
TABLE 396 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 338
TABLE 397 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 339
TABLE 398 ITALY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 339
TABLE 399 ITALY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 340
TABLE 400 ITALY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 340
TABLE 401 ITALY: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 340
TABLE 402 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 341
TABLE 403 ITALY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 341
TABLE 404 ITALY: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 342
TABLE 405 ITALY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 342
TABLE 406 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 343
10.3.6 SPAIN 343
10.3.6.1 High incidence of cancer and focus on translational and personalized medicines to augment market growth 343
TABLE 407 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 344
TABLE 408 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 344
TABLE 409 SPAIN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 345
TABLE 410 SPAIN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 345
TABLE 411 SPAIN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 345
TABLE 412 SPAIN: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 346
TABLE 413 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 346
TABLE 414 SPAIN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 347
TABLE 415 SPAIN: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 347
TABLE 416 SPAIN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 348
TABLE 417 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 348
10.3.7 REST OF EUROPE 348
TABLE 418 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 349
TABLE 419 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 350
TABLE 420 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 350
TABLE 421 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 351
TABLE 422 REST OF EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 351
TABLE 423 REST OF EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 351
TABLE 424 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 352
TABLE 425 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 352
TABLE 426 REST OF EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 353
TABLE 427 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 353
TABLE 428 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 354
10.4 ASIA PACIFIC 354
FIGURE 35 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT 355
TABLE 429 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD BILLION) 356
TABLE 430 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD BILLION) 356
TABLE 431 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD BILLION) 357
TABLE 432 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD BILLION) 357
TABLE 433 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD BILLION) 358
TABLE 434 ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 358
TABLE 435 ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD BILLION) 359
TABLE 436 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD BILLION) 359
TABLE 437 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 360
TABLE 438 ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 360
TABLE 439 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD BILLION) 361
TABLE 440 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD BILLION) 361
10.4.1 ASIA PACIFIC: RECESSION IMPACT 361
10.4.2 JAPAN 362
10.4.2.1 Technological advancements and high prevalence of chronic diseases to drive market 362
TABLE 441 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 363
TABLE 442 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 363
TABLE 443 JAPAN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 363
TABLE 444 JAPAN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 364
TABLE 445 JAPAN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 364
TABLE 446 JAPAN: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 364
TABLE 447 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 365
TABLE 448 JAPAN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 365
TABLE 449 JAPAN: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 366
TABLE 450 JAPAN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 366
TABLE 451 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 367
10.4.3 CHINA 367
10.4.3.1 High incidence of cancer and favorable government policies to support market growth 367
TABLE 452 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 368
TABLE 453 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 368
TABLE 454 CHINA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 369
TABLE 455 CHINA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 369
TABLE 456 CHINA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 369
TABLE 457 CHINA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 370
TABLE 458 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 370
TABLE 459 CHINA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 371
TABLE 460 CHINA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 371
TABLE 461 CHINA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 372
TABLE 462 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 372
10.4.4 INDIA 372
10.4.4.1 Rising government funding for proteomics research to drive market 372
TABLE 463 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 374
TABLE 464 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 374
TABLE 465 INDIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 375
TABLE 466 INDIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 375
TABLE 467 INDIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 375
TABLE 468 INDIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 376
TABLE 469 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 376
TABLE 470 INDIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 377
TABLE 471 INDIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 377
TABLE 472 INDIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 378
TABLE 473 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 378
10.4.5 AUSTRALIA 378
10.4.5.1 Increasing government research funding and growing prevalence of cancer to propel market growth 378
TABLE 474 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 380
TABLE 475 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 380
TABLE 476 AUSTRALIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 381
TABLE 477 AUSTRALIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 381
TABLE 478 AUSTRALIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 381
TABLE 479 AUSTRALIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 382
TABLE 480 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 382
TABLE 481 AUSTRALIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 383
TABLE 482 AUSTRALIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 383
TABLE 483 AUSTRALIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 384
TABLE 484 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 384
10.4.6 SOUTH KOREA 384
10.4.6.1 Rising number of conferences and growing focus on medical research to spur market growth 384
TABLE 485 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 385
TABLE 486 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 386
TABLE 487 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 386
TABLE 488 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 387
TABLE 489 SOUTH KOREA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 387
TABLE 490 SOUTH KOREA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 388
TABLE 491 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 388
TABLE 492 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 389
TABLE 493 SOUTH KOREA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 389
TABLE 494 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 390
TABLE 495 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 390
10.4.7 SINGAPORE 390
10.4.7.1 Increasing availability of data analysis software and growing focus on medical tourism to drive market 390
TABLE 496 SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 392
TABLE 497 SINGAPORE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 392
TABLE 498 SINGAPORE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 392
TABLE 499 SINGAPORE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 393
TABLE 500 SINGAPORE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 393
TABLE 501 SINGAPORE: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 393
TABLE 502 SINGAPORE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 394
TABLE 503 SINGAPORE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 394
TABLE 504 SINGAPORE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 395
TABLE 505 SINGAPORE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 395
TABLE 506 SINGAPORE: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 396
10.4.8 INDONESIA 396
10.4.8.1 Rising prevalence of HIV and cancer to drive market 396
TABLE 507 INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 397
TABLE 508 INDONESIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 397
TABLE 509 INDONESIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 398
TABLE 510 INDONESIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 398
TABLE 511 INDONESIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 398
TABLE 512 INDONESIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 399
TABLE 513 INDONESIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 399
TABLE 514 INDONESIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 400
TABLE 515 INDONESIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 400
TABLE 516 INDONESIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 401
TABLE 517 INDONESIA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 401
10.4.9 REST OF ASIA PACIFIC 402
TABLE 518 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 402
TABLE 519 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 403
TABLE 520 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 403
TABLE 521 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 404
TABLE 522 REST OF ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 404
TABLE 523 REST OF ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 405
TABLE 524 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 405
TABLE 525 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 406
TABLE 526 REST OF ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 406
TABLE 527 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 407
TABLE 528 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 407
10.5 LATIN AMERICA 408
TABLE 529 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 408
TABLE 530 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 408
TABLE 531 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 409
TABLE 532 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 409
TABLE 533 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 410
TABLE 534 LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 410
TABLE 535 LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 410
TABLE 536 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 411
TABLE 537 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 411
TABLE 538 LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 412
TABLE 539 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 412
TABLE 540 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 413
10.5.1 LATIN AMERICA: RECESSION IMPACT 413
10.5.2 BRAZIL 414
10.5.2.1 Presence of key market players and increased emphasis on cancer research to boost market growth 414
TABLE 541 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 414
TABLE 542 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 415
TABLE 543 BRAZIL: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 415
TABLE 544 BRAZIL: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 416
TABLE 545 BRAZIL: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 416
TABLE 546 BRAZIL: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 416
TABLE 547 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 417
TABLE 548 BRAZIL: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 417
TABLE 549 BRAZIL: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 418
TABLE 550 BRAZIL: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 418
TABLE 551 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 419
10.5.3 MEXICO 419
10.5.3.1 Favorable trade agreements and growth of pharmaceutical industry to fuel market growth 419
TABLE 552 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 420
TABLE 553 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 420
TABLE 554 MEXICO: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 421
TABLE 555 MEXICO: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 421
TABLE 556 MEXICO: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 421
TABLE 557 MEXICO: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 422
TABLE 558 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 422
TABLE 559 MEXICO: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 423
TABLE 560 MEXICO: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 423
TABLE 561 MEXICO: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 424
TABLE 562 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 424
10.5.4 REST OF LATIN AMERICA 424
TABLE 563 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 425
TABLE 564 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 425
TABLE 565 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 426
TABLE 566 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 426
TABLE 567 REST OF LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 427
TABLE 568 REST OF LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 427
TABLE 569 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 428
TABLE 570 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 428
TABLE 571 REST OF LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 429
TABLE 572 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 429
TABLE 573 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 430
10.6 MIDDLE EAST 430
TABLE 574 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 431
TABLE 575 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 431
TABLE 576 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 431
TABLE 577 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 432
TABLE 578 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 432
TABLE 579 MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 433
TABLE 580 MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 433
TABLE 581 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 433
TABLE 582 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 434
TABLE 583 MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 434
TABLE 584 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 435
TABLE 585 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 435
10.6.1 GCC COUNTRIES 435
TABLE 586 GCC COUNTRIES: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 436
TABLE 587 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 436
TABLE 588 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 437
TABLE 589 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 437
TABLE 590 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 438
TABLE 591 GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 438
TABLE 592 GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 439
TABLE 593 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 439
TABLE 594 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 440
TABLE 595 GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 440
TABLE 596 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 441
TABLE 597 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 441
10.6.1.1 Saudi Arabia 441
10.6.1.1.1 Growing prevalence of chronic diseases and increasing R&D investments to boost market growth 441
TABLE 598 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 442
TABLE 599 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 443
TABLE 600 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 443
TABLE 601 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 444
TABLE 602 SAUDI ARABIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 444
TABLE 603 SAUDI ARABIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 444
TABLE 604 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 445
TABLE 605 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 445
TABLE 606 SAUDI ARABIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 446
TABLE 607 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 446
TABLE 608 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 447
10.6.1.2 UAE 447
10.6.1.2.1 Increased R&D investment and favorable government healthcare policies to drive market 447
TABLE 609 UAE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 448
TABLE 610 UAE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 448
TABLE 611 UAE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 449
TABLE 612 UAE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 449
TABLE 613 UAE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 450
TABLE 614 UAE: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 450
TABLE 615 UAE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 451
TABLE 616 UAE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 451
TABLE 617 UAE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 452
TABLE 618 UAE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 452
TABLE 619 UAE: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 453
10.6.1.3 Other GCC countries 453
TABLE 620 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 454
TABLE 621 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 454
TABLE 622 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 455
TABLE 623 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 455
TABLE 624 OTHER GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 456
TABLE 625 OTHER GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 456
TABLE 626 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 457
TABLE 627 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 457
TABLE 628 OTHER GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 458
TABLE 629 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 458
TABLE 630 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 459
10.6.2 REST OF MIDDLE EAST 459
TABLE 631 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 460
TABLE 632 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 460
TABLE 633 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 461
TABLE 634 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 461
TABLE 635 REST OF MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 462
TABLE 636 REST OF MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 462
TABLE 637 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 463
TABLE 638 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 463
TABLE 639 REST OF MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 464
TABLE 640 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 464
TABLE 641 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 465
10.7 AFRICA 465
10.7.1 INCREASING BURDEN OF INFECTIOUS AND NON-COMMUNICABLE DISEASES TO PROPEL MARKET GROWTH 465
TABLE 642 AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 (USD MILLION) 466
TABLE 643 AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022-2032 (USD MILLION) 466
TABLE 644 AFRICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2032 (USD MILLION) 467
TABLE 645 AFRICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2032 (USD MILLION) 467
TABLE 646 AFRICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 468
TABLE 647 AFRICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022-2032 (USD MILLION) 468
TABLE 648 AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 (USD MILLION) 469
TABLE 649 AFRICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 469
TABLE 650 AFRICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022-2032 (USD MILLION) 470
TABLE 651 AFRICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2032 (USD MILLION) 470
TABLE 652 AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 (USD MILLION) 471
10.7.2 AFRICA: RECESSION IMPACT 471
11 COMPETITIVE LANDSCAPE 472
11.1 OVERVIEW 472
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 472
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET 472
TABLE 653 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET 472
?
11.3 REVENUE ANALYSIS 474
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN FLOW CYTOMETRY MARKET, 2021-2023 (USD MILLION) 474
11.4 MARKET SHARE ANALYSIS 475
FIGURE 37 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023 475
TABLE 654 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION 476
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 477
11.5.1 STARS 477
11.5.2 EMERGING LEADERS 477
11.5.3 PERVASIVE PLAYERS 477
11.5.4 PARTICIPANTS 477
FIGURE 38 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 478
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 479
11.5.5.1 Company footprint 479
FIGURE 39 FLOW CYTOMETRY MARKET: COMPANY FOOTPRINT 479
11.5.5.2 Product & service footprint 480
TABLE 655 FLOW CYTOMETRY MARKET: PRODUCT & SERVICE FOOTPRINT 480
11.5.5.3 Region footprint 481
TABLE 656 FLOW CYTOMETRY MARKET: REGION FOOTPRINT 481
11.5.5.4 Application footprint 482
TABLE 657 FLOW CYTOMETRY MARKET: APPLICATION FOOTPRINT 482
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 483
11.6.1 PROGRESSIVE COMPANIES 483
11.6.2 RESPONSIVE COMPANIES 483
11.6.3 DYNAMIC COMPANIES 483
11.6.4 STARTING BLOCKS 483
FIGURE 40 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 484
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 485
TABLE 658 FLOW CYTOMETRY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 485
TABLE 659 FLOW CYTOMETRY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 486
11.7 VALUATION & FINANCIAL METRICS 486
11.7.1 VALUATION OF KEY PLAYERS 486
FIGURE 41 EV/EBITDA OF KEY PLAYERS 486
11.7.2 FINANCIAL METRICS OF KEY PLAYERS 487
FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS 487
11.8 BRAND/PRODUCT COMPARISON 488
FIGURE 43 FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF CELL SORTERS 488
FIGURE 44 FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF CELL ANALYZERS 489
11.9 COMPETITIVE SCENARIO 490
11.9.1 PRODUCT LAUNCHES & APPROVALS 490
TABLE 660 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 490
11.9.2 DEALS 491
TABLE 661 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2021-MAY 2024 491
12 COMPANY PROFILES 492
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS 492
12.1.1 BECTON, DICKINSON AND COMPANY 492
TABLE 662 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 492
FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 493
TABLE 663 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 493
TABLE 664 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 497
TABLE 665 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-MAY 2024 498
12.1.2 DANAHER CORPORATION 499
TABLE 666 DANAHER CORPORATION: COMPANY OVERVIEW 499
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 500
TABLE 667 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 501
TABLE 668 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 503
TABLE 669 DANAHER CORPORATION: DEALS, JANUARY 2021-MAY 2024 503
12.1.3 THERMO FISHER SCIENTIFIC INC. 505
TABLE 670 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 505
FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 506
TABLE 671 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 506
TABLE 672 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 507
TABLE 673 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-MAY 2024 507
12.1.4 AGILENT TECHNOLOGIES, INC. 509
TABLE 674 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 509
FIGURE 48 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 510
TABLE 675 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 511
TABLE 676 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 512
12.1.5 SONY CORPORATION 513
TABLE 677 SONY CORPORATION: COMPANY OVERVIEW 513
FIGURE 49 SONY CORPORATION: COMPANY SNAPSHOT (2023) 514
TABLE 678 SONY CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 514
TABLE 679 SONY CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 516
12.1.6 BIO-RAD LABORATORIES, INC. 517
TABLE 680 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 517
FIGURE 50 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 518
TABLE 681 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 518
TABLE 682 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 519
12.1.7 MILTENYI BIOTEC 520
TABLE 683 MILTENYI BIOTEC: COMPANY OVERVIEW 520
TABLE 684 MILTENYI BIOTEC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 520
12.1.8 ENZO BIOCHEM INC. 522
TABLE 685 ENZO BIOCHEM INC.: COMPANY OVERVIEW 522
FIGURE 51 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023) 523
TABLE 686 ENZO BIOCHEM INC.: PRODUCTS/ SERVICES/SOLUTIONS OFFERED 523
12.1.9 SYSMEX CORPORATION 525
TABLE 687 SYSMEX CORPORATION: COMPANY OVERVIEW 525
FIGURE 52 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022) 526
TABLE 688 SYSMEX CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 527
TABLE 689 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 527
12.1.10 CYTEK BIOSCIENCES 528
TABLE 690 CYTEK BIOSCIENCES: COMPANY OVERVIEW 528
FIGURE 53 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2023) 529
TABLE 691 CYTEK BIOSCIENCES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 529
TABLE 692 CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 530
TABLE 693 CYTEK BIOSCIENCES: DEALS, JANUARY 2021-MAY 2024 531
12.1.11 BIOMERIEUX 532
TABLE 694 BIOMERIEUX: COMPANY OVERVIEW 532
FIGURE 54 BIOMERIEUX: COMPANY SNAPSHOT (2023) 533
TABLE 695 BIOMERIEUX: PRODUCTS/SERVICES/SOLUTIONS OFFERED 533
12.1.12 CYTONOME/ST, LLC 534
TABLE 696 CYTONOME/ST, LLC: COMPANY OVERVIEW 534
TABLE 697 CYTONOME/ST, LLC: PRODUCTS/ SERVICES/SOLUTIONS OFFERED 534
12.1.13 SARTORIUS AG 535
TABLE 698 SARTORIUS AG: COMPANY OVERVIEW 535
FIGURE 55 SARTORIUS AG: COMPANY SNAPSHOT (2023) 536
TABLE 699 SARTORIUS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 537
12.1.14 UNION BIOMETRICA, INC. 538
TABLE 700 UNION BIOMETRICA, INC.: COMPANY OVERVIEW 538
TABLE 701 UNION BIOMETRICA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 538
12.1.15 TAKARA BIO INC. 539
TABLE 702 TAKARA BIO INC.: COMPANY OVERVIEW 539
FIGURE 56 TAKARA BIO INC.: COMPANY SNAPSHOT (2023) 540
TABLE 703 TAKARA BIO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 540
12.2 OTHER PLAYERS 542
12.2.1 APOGEE FLOW SYSTEMS LTD. 542
TABLE 704 APOGEE FLOW SYSTEMS LTD.: COMPANY OVERVIEW 542
12.2.2 STRATEDIGM, INC. 543
TABLE 705 STRATEDIGM, INC.: COMPANY OVERVIEW 543
12.2.3 NANOCELLECT BIOMEDICAL 544
TABLE 706 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW 544
12.2.4 BIOLEGEND, INC. 545
TABLE 707 BIOLEGEND, INC.: COMPANY OVERVIEW 545
12.2.5 ON-CHIP BIOTECHNOLOGIES CO., LTD. 546
TABLE 708 ON-CHIP BIOTECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 546
12.2.6 NEXCELOM BIOSCIENCE LLC 547
TABLE 709 NEXCELOM BIOSCIENCE LLC: COMPANY OVERVIEW 547
12.2.7 BENNUBIO INC. 548
TABLE 710 BENNUBIO INC.: COMPANY OVERVIEW 548
12.2.8 ORFLO TECHNOLOGIES 549
TABLE 711 ORFLO TECHNOLOGIES: COMPANY OVERVIEW 549
12.2.9 BAY BIOSCIENCE LLC 550
TABLE 712 BAY BIOSCIENCE LLC: COMPANY OVERVIEW 550
12.2.10 CYTOBUOY 550
TABLE 713 CYTOBUOY: COMPANY OVERVIEW 550
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 551
13.1 DISCUSSION GUIDE 551
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 556
13.3 CUSTOMIZATION OPTIONS 558
13.4 RELATED REPORTS 558
13.5 AUTHOR DETAILS 559
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security